Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

MRNS | Marinus Pharmaceuticals Inc

IndexRUT P/E- EPS (ttm)-0.15 Insider Own6.21% Shs Outstand49.64M Perf Week22.01%
Market Cap361.86M Forward P/E- EPS next Y-2.36 Insider Trans-0.53% Shs Float47.47M Perf Month2.29%
Income-29.34M PEG- EPS next Q-0.66 Inst Own84.33% Short Float / Ratio7.56% / 4.43 Perf Quarter-29.28%
Sales25.96M P/S13.94 EPS this Y-408.02% Inst Trans1.43% Short Interest3.59M Perf Half Y15.32%
Book/sh1.13 P/B6.31 EPS next Y9.05% ROA-17.83% Target Price20.60 Perf Year4.99%
Cash/sh3.46 P/C2.06 EPS next 5Y80.66% ROE-89.11% 52W Range3.46 - 11.15 Perf YTD79.65%
Dividend- P/FCF- EPS past 5Y30.82% ROI-18.50% 52W High-35.87% Beta1.36
Dividend %- Quick Ratio7.50 Sales past 5Y171.84% Gross Margin93.67% 52W Low106.35% ATR0.57
Employees151 Current Ratio7.60 Sales Q/Q239.72% Oper. Margin-476.50% RSI (14)50.22 Volatility11.77% 7.67%
OptionableYes Debt/Eq1.87 EPS Q/Q42.74% Profit Margin-113.01% Rel Volume0.78 Prev Close6.60
ShortableYes LT Debt/Eq1.77 EarningsAug 10 BMO Payout- Avg Volume810.90K Price7.15
Recom1.27 SMA203.89% SMA50-11.28% SMA200-3.09% Volume628,848 Change8.33%
Date Action Analyst Rating Change Price Target Change
Aug-11-23Downgrade Oppenheimer Outperform → Perform $14 → $9
Jan-20-23Initiated RBC Capital Mkts Outperform $23
Sep-30-20Initiated Truist Buy $35
Jul-01-20Reiterated H.C. Wainwright Buy $6 → $9
Jul-01-20Initiated Cowen Outperform
Apr-09-20Initiated Craig Hallum Buy $4.50
Dec-20-19Initiated Oppenheimer Outperform
Mar-05-19Resumed Jefferies Buy $3.50 → $10
Feb-27-19Downgrade Mizuho Buy → Neutral $13 → $5
Feb-06-19Initiated Leerink Partners Outperform $10
Sep-21-23 04:00PM
Sep-20-23 09:02AM
Sep-19-23 04:51PM
04:00PM Loading…
Sep-12-23 04:00PM
Sep-06-23 04:01PM
Aug-17-23 04:01PM
Aug-11-23 04:01PM
Aug-10-23 08:40AM
Jul-31-23 12:03PM
07:01AM Loading…
Jul-27-23 07:01AM
Jul-25-23 03:48PM
Jul-13-23 04:30PM
Jul-03-23 04:23AM
Jun-21-23 04:01PM
Jun-12-23 07:59AM
Jun-02-23 04:30PM
May-26-23 08:10AM
May-17-23 04:01PM
May-16-23 11:50AM
May-11-23 08:35AM
May-09-23 04:01PM
10:00AM Loading…
May-04-23 10:00AM
May-03-23 07:01AM
Apr-27-23 07:01AM
Apr-18-23 11:03AM
Apr-06-23 04:00PM
Mar-22-23 09:01AM
Mar-08-23 12:12PM
Mar-07-23 05:15PM
Mar-06-23 04:01PM
Feb-15-23 01:00PM
Feb-13-23 07:15AM
Feb-10-23 04:01PM
Feb-07-23 07:15AM
Jan-30-23 04:01PM
Jan-20-23 02:17PM
Jan-09-23 04:17PM
Jan-05-23 04:01PM
Dec-30-22 12:46AM
Dec-21-22 07:20AM
Dec-09-22 04:01PM
Nov-30-22 04:01PM
Nov-18-22 09:00AM
Nov-17-22 01:47PM
Nov-10-22 12:59PM
Nov-07-22 11:12PM
Nov-04-22 10:55AM
Nov-01-22 10:01AM
Oct-31-22 07:30AM
Oct-26-22 09:28AM
Oct-25-22 07:30AM
Oct-20-22 02:41PM
Oct-14-22 04:30PM
Oct-11-22 07:30AM
Sep-22-22 10:55AM
Sep-09-22 04:05PM
Sep-08-22 09:03AM
Sep-07-22 07:30AM
Aug-29-22 04:01PM
Aug-12-22 08:12AM
Aug-11-22 08:55AM
Aug-05-22 07:29AM
Jul-28-22 07:30AM
Jul-25-22 12:04PM
Jul-15-22 04:05PM
Jul-14-22 11:07AM
Jul-13-22 07:30AM
Jun-25-22 10:34AM
Jun-08-22 07:30AM
Jun-03-22 04:01PM
Jun-02-22 10:57AM
May-18-22 09:00AM
May-12-22 05:35PM
Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded in August 2003 and is headquartered in Radnor, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Braunstein ScottCHAIRMAN AND CEOAug 08Sale8.9430268160,762Aug 08 09:05 PM
Pfanstiel StevenCFO AND COOAug 08Sale8.931412549,324Aug 08 09:05 PM
Hulihan JosephCHIEF MEDICAL OFFICERAug 08Sale8.931311647,614Aug 08 09:05 PM
MANNING MARTHA ESVP, GEN. COUNSEL & CORP. SEC.Aug 08Sale8.93119833,025Aug 08 09:05 PM
Shafer ChristinaCHIEF COMMERCIAL OFFICERAug 08Sale8.93119840,626Aug 08 09:05 PM
Braunstein ScottCHAIRMAN AND CEOAug 07Sale9.556,41361,244160,792Aug 08 09:05 PM
Hulihan JosephCHIEF MEDICAL OFFICERAug 07Sale9.552,88927,59047,627Aug 08 09:05 PM
Pfanstiel StevenCFO AND COOAug 07Sale9.542,79026,61749,338Aug 08 09:05 PM
Shafer ChristinaCHIEF COMMERCIAL OFFICERAug 07Sale9.522,38522,70540,637Aug 08 09:05 PM
MANNING MARTHA ESVP, GEN. COUNSEL & CORP. SEC.Aug 07Sale9.542,16920,69233,036Aug 08 09:05 PM
Austin CharlesDirectorFeb 06Sale6.491,0736,9645,277Feb 08 04:36 PM
Fischer Seth H. Z.DirectorFeb 06Sale6.541,0186,6586,026Feb 08 04:37 PM
Ezickson ElanDirectorFeb 06Sale6.567504,9205,600Feb 08 04:36 PM